SNGX - Financial Reports List - Soligenix, Inc. - IntrinsicAlpha

Soligenix, Inc. SNGX

Healthcare - Biotechnology - NASDAQ - US

$ 2.055

-1.43 %

$ 6.48 M

Market Cap

-0.42

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-64.15%	-55.81%
Annual Report	FY	10-K	2024-12-31	-85.78%	-41.28%	-22.62%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-3.41%	-4.84%
Quarterly Report	Q2	8-K	2024-06-30	-98.87%	-2.01%	-7.16%
Quarterly Report	Q1	8-K	2024-03-31	-54.49%	-83.09%	-4.19%
Quarterly Report	Q4	8-K	2023-12-31	-33.12%	51.52%	33.33%
Annual Report	FY	10-K	2023-12-31	-11.55%	55.50%	45.43%
Quarterly Report	Q3	8-K	2023-09-30	-21.49%	49.75%	42.26%
Quarterly Report	Q2	8-K	2023-06-30	-9.50%	32.46%	51.98%
Quarterly Report	Q1	8-K	2023-03-31	36.75%	75.95%	46.91%

1